Search Results

Optionality in Australian Football League draftee contracts.

• Authors : Chandrakumaran J; Institute for Health and Sport (IHES), Victoria University, Melbourne, Australia.; Larkin P

Subjects: Athletes* ; Cancer Vaccines*; Humans

• Source: PloS one [PLoS One] 2023 Sep 14; Vol. 18 (9), pp. e0291439. Date of Electronic Publication: 2023 Sep 14 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Efficacy of a synthetic peptide Chlamydia pecorum major outer membrane protein vaccine in a wild koala (Phascolarctos cinereus) population.

• Authors : Simpson SJ; Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW, 2006, Australia. .; Higgins DP

Subjects: Cancer Vaccines* ; Phascolarctidae* ; Psittacosis*Chlamydia pecorum

• Source: Scientific reports [Sci Rep] 2023 Sep 12; Vol. 13 (1), pp. 15087. Date of Electronic Publication: 2023 Sep 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations.

• Authors : Guo L; Department of Obstetrics and Gynecology, Division of Vaccine Research, The Ohio State Wexner Medical Center, Columbus, OH, USA.; Kaumaya PTP

Subjects: Cancer Vaccines* ; Lung Neoplasms*; Australia

• Source: British journal of cancer [Br J Cancer] 2021 Jul; Vol. 125 (2), pp. 152-154. Date of Electronic Publication: 2021 Mar Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication

Record details

Investigators at University of Tasmania Report Findings in Cancer Vaccines (Generation of Devil Facial Tumour Cells Co-expressing Mhc With Cd80, Cd86 or 41bbl To Enhance Tumour Immunogenicity).

• Source: Vaccine Weekly. 2024, pages. 44

Record details

Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.

• Authors : Kreiss A; Menzies Institute for Medical Research Tasmania, University of Tasmania, Tasmania, Australia. Electronic address: .; Brown GK

Subjects: Cytotoxicity, Immunologic* ; Immunity, Humoral*; Antibodies, Neoplasm/Antibodies, Neoplasm/Antibodies, Neoplasm/*blood

• Source: Vaccine [Vaccine] 2015 Jun 12; Vol. 33 (26), pp. 3016-25. Date of Electronic Publication: 2015 Feb 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

• Authors : Murphy R; Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Austin Hospital, Heidelberg, Australia. ; Green S

Subjects: Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*biosynthesis ; Antigens, Neoplasm/Antigens, Neoplasm/Antigens, Neoplasm/*isolation & purification ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*biosynthesis

• Source: Preparative biochemistry & biotechnology [Prep Biochem Biotechnol] 2005; Vol. 35 (2), pp. 119-34.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9607037 Publication Model: Print Cited Medium: Print ISSN: 1082-6068 (Print)

Record details

Progress towards achieving new vaccine and vaccination goals.

• Authors : Ada G; John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.

Subjects: Bacterial Vaccines/Bacterial Vaccines/Bacterial Vaccines/*administration & dosage ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*administration & dosage ; Communicable Disease Control/Communicable Disease Control/Communicable Disease Control/*organization & administration

• Source: Internal medicine journal [Intern Med J] 2003 Jul; Vol. 33 (7), pp. 297-304.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print Cited Medium:

Record details

Melanoma vaccine launched in Australia.

• Authors : Timms B

Subjects: Cancer Vaccines*; Melanoma/Melanoma/Melanoma/*prevention & control; Australia

• Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2000 Oct; Vol. 36 (15), pp. 1886.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print Cited Medium: Print ISSN: 0959-8049

Record details

Investigators at University of Tasmania Report Findings in Cancer Vaccines (Generation of Devil Facial Tumour Cells Co-expressing Mhc With Cd80, Cd86 or 41bbl To Enhance Tumour Immunogenicity).

Subjects: MONONUCLEAR leukocytes; TRANSMISSIBLE tumors; CANCER vaccinesHOBART (Tas.); AUSTRALIA

• Source: Cancer Vaccine Week; 10/21/2024, p44-44, 1p

Record details

Prophylactic human papillomavirus vaccines: past, present and future.

• Authors : Anderson LA; Department of Tissue Pathology, ICPMR, Westmead Hospital, Wentworthville, New South Wales, Australia.

Subjects: Alphapapillomavirus/Alphapapillomavirus/Alphapapillomavirus/*immunology ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*administration & dosage ; Papillomavirus Infections/Papillomavirus Infections/Papillomavirus Infections/*prevention & control

• Source: Pathology [Pathology] 2012 Jan; Vol. 44 (1), pp. 1-6.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print Cited Medium: Internet ISSN:

Record details